 Hanan Elajaili
Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electron Spin Resonance Spectroscopy | 18 | 2023 | 97 | 2.860 |
Why?
| | Reactive Oxygen Species | 5 | 2025 | 621 | 1.470 |
Why?
| | Nitrogen Oxides | 9 | 2023 | 54 | 1.350 |
Why?
| | Superoxides | 4 | 2025 | 204 | 1.130 |
Why?
| | Superoxide Dismutase | 3 | 2025 | 301 | 0.900 |
Why?
| | Quinones | 2 | 2015 | 8 | 0.890 |
Why?
| | Acute Lung Injury | 3 | 2023 | 303 | 0.880 |
Why?
| | Oxidation-Reduction | 6 | 2023 | 1087 | 0.870 |
Why?
| | Hydroxylamine | 1 | 2023 | 7 | 0.810 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2025 | 198 | 0.810 |
Why?
| | Mice, Inbred C57BL | 7 | 2025 | 5992 | 0.770 |
Why?
| | Wound Healing | 1 | 2025 | 351 | 0.730 |
Why?
| | Lung | 8 | 2025 | 4109 | 0.590 |
Why?
| | Disease Models, Animal | 5 | 2025 | 4557 | 0.540 |
Why?
| | Electrons | 2 | 2014 | 88 | 0.520 |
Why?
| | Nails | 1 | 2016 | 13 | 0.490 |
Why?
| | Radiometry | 1 | 2016 | 56 | 0.490 |
Why?
| | Biological Assay | 1 | 2016 | 128 | 0.470 |
Why?
| | Temperature | 1 | 2019 | 679 | 0.460 |
Why?
| | Disulfides | 1 | 2015 | 96 | 0.450 |
Why?
| | Alcohols | 1 | 2014 | 28 | 0.430 |
Why?
| | Inflammation | 2 | 2025 | 2878 | 0.420 |
Why?
| | Sulfhydryl Compounds | 1 | 2015 | 189 | 0.400 |
Why?
| | Oxidative Stress | 5 | 2025 | 1339 | 0.390 |
Why?
| | Mice | 12 | 2025 | 18339 | 0.330 |
Why?
| | Glutathione | 2 | 2024 | 375 | 0.280 |
Why?
| | Bleomycin | 2 | 2021 | 253 | 0.280 |
Why?
| | Free Radicals | 3 | 2015 | 110 | 0.240 |
Why?
| | Animals | 13 | 2025 | 38058 | 0.240 |
Why?
| | Kidney | 2 | 2024 | 1495 | 0.220 |
Why?
| | Pneumonia, Staphylococcal | 1 | 2025 | 27 | 0.220 |
Why?
| | Acute Kidney Injury | 2 | 2024 | 865 | 0.220 |
Why?
| | Cerium | 2 | 2021 | 19 | 0.210 |
Why?
| | Cell Communication | 1 | 2025 | 324 | 0.190 |
Why?
| | Mitochondria | 2 | 2020 | 984 | 0.190 |
Why?
| | Uncoupling Protein 2 | 1 | 2022 | 9 | 0.190 |
Why?
| | Antimycin A | 2 | 2020 | 14 | 0.190 |
Why?
| | Oxygen | 4 | 2016 | 995 | 0.190 |
Why?
| | Fibroblasts | 2 | 2025 | 1034 | 0.180 |
Why?
| | Blood Platelets | 1 | 2025 | 400 | 0.170 |
Why?
| | Deuterium | 4 | 2014 | 100 | 0.170 |
Why?
| | Myofibroblasts | 1 | 2022 | 143 | 0.170 |
Why?
| | Succinate Dehydrogenase | 1 | 2021 | 57 | 0.170 |
Why?
| | Phantoms, Imaging | 3 | 2016 | 158 | 0.160 |
Why?
| | Catechin | 1 | 2020 | 22 | 0.160 |
Why?
| | Lipopolysaccharides | 1 | 2023 | 863 | 0.150 |
Why?
| | tat Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 25 | 0.150 |
Why?
| | Neutrophils | 1 | 2025 | 1134 | 0.150 |
Why?
| | Equipment Failure Analysis | 2 | 2016 | 128 | 0.140 |
Why?
| | Cell Compartmentation | 1 | 2019 | 54 | 0.140 |
Why?
| | RAW 264.7 Cells | 1 | 2019 | 50 | 0.140 |
Why?
| | Reperfusion Injury | 1 | 2022 | 300 | 0.140 |
Why?
| | Spin Labels | 3 | 2014 | 59 | 0.140 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2019 | 95 | 0.140 |
Why?
| | Electromagnetic Fields | 2 | 2015 | 37 | 0.140 |
Why?
| | Lung Injury | 1 | 2021 | 237 | 0.140 |
Why?
| | Mice, Knockout | 2 | 2023 | 3121 | 0.140 |
Why?
| | Algorithms | 3 | 2015 | 1837 | 0.140 |
Why?
| | Energy Metabolism | 1 | 2024 | 935 | 0.140 |
Why?
| | Hyaluronic Acid | 1 | 2020 | 208 | 0.130 |
Why?
| | Glioma | 1 | 2022 | 425 | 0.130 |
Why?
| | Drug Delivery Systems | 1 | 2021 | 380 | 0.130 |
Why?
| | Equipment Design | 2 | 2016 | 530 | 0.130 |
Why?
| | Macrophages | 1 | 2025 | 1511 | 0.130 |
Why?
| | Molecular Structure | 2 | 2017 | 499 | 0.130 |
Why?
| | Carboxylic Acids | 1 | 2017 | 34 | 0.130 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2016 | 561 | 0.130 |
Why?
| | Sensitivity and Specificity | 3 | 2016 | 1985 | 0.120 |
Why?
| | Triacetoneamine-N-Oxyl | 2 | 2014 | 2 | 0.120 |
Why?
| | Microwaves | 1 | 2016 | 31 | 0.120 |
Why?
| | Cattle | 1 | 2019 | 1000 | 0.120 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2019 | 636 | 0.120 |
Why?
| | Pyrroles | 1 | 2017 | 217 | 0.110 |
Why?
| | Antioxidants | 1 | 2019 | 549 | 0.110 |
Why?
| | Liver | 1 | 2024 | 1887 | 0.110 |
Why?
| | Nanoparticles | 1 | 2021 | 519 | 0.110 |
Why?
| | Spin Trapping | 1 | 2014 | 3 | 0.110 |
Why?
| | Pneumonia | 1 | 2021 | 631 | 0.110 |
Why?
| | Protons | 1 | 2015 | 95 | 0.110 |
Why?
| | Idiopathic Pulmonary Fibrosis | 1 | 2022 | 691 | 0.110 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2014 | 630 | 0.110 |
Why?
| | In Vitro Techniques | 1 | 2016 | 1047 | 0.110 |
Why?
| | MicroRNAs | 1 | 2021 | 701 | 0.110 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2015 | 151 | 0.110 |
Why?
| | Methanol | 1 | 2014 | 46 | 0.110 |
Why?
| | Hydrogen Bonding | 1 | 2014 | 169 | 0.100 |
Why?
| | Hydroxyl Radical | 1 | 2014 | 95 | 0.100 |
Why?
| | Magnetics | 1 | 2014 | 48 | 0.100 |
Why?
| | Transducers | 1 | 2014 | 26 | 0.100 |
Why?
| | Molecular Imaging | 1 | 2014 | 55 | 0.100 |
Why?
| | Reproducibility of Results | 3 | 2016 | 3409 | 0.100 |
Why?
| | Endothelium, Vascular | 1 | 2020 | 965 | 0.100 |
Why?
| | Indicators and Reagents | 4 | 2014 | 106 | 0.100 |
Why?
| | Models, Biological | 1 | 2020 | 1821 | 0.090 |
Why?
| | Hypoxia | 1 | 2020 | 1199 | 0.090 |
Why?
| | Male | 6 | 2024 | 72315 | 0.080 |
Why?
| | Antineoplastic Agents | 1 | 2022 | 2194 | 0.080 |
Why?
| | Ethanol | 1 | 2014 | 627 | 0.080 |
Why?
| | Nitrogen Radioisotopes | 3 | 2014 | 5 | 0.070 |
Why?
| | Anisotropy | 3 | 2013 | 75 | 0.070 |
Why?
| | Hypertension, Pulmonary | 1 | 2020 | 1980 | 0.070 |
Why?
| | Mice, Transgenic | 2 | 2025 | 2182 | 0.070 |
Why?
| | Signal Transduction | 2 | 2020 | 5226 | 0.060 |
Why?
| | Neutrophil Infiltration | 1 | 2025 | 104 | 0.050 |
Why?
| | Platelet Activation | 1 | 2025 | 104 | 0.050 |
Why?
| | HIV Infections | 1 | 2019 | 3154 | 0.050 |
Why?
| | Time Factors | 1 | 2014 | 7173 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 1 | 2015 | 3863 | 0.050 |
Why?
| | Nitrogen Isotopes | 2 | 2013 | 72 | 0.050 |
Why?
| | Glycolysis | 1 | 2024 | 339 | 0.050 |
Why?
| | Radiation, Ionizing | 1 | 2022 | 87 | 0.040 |
Why?
| | Solutions | 2 | 2012 | 166 | 0.040 |
Why?
| | Female | 3 | 2025 | 78271 | 0.040 |
Why?
| | Ischemia | 1 | 2024 | 421 | 0.040 |
Why?
| | Humans | 8 | 2022 | 144759 | 0.040 |
Why?
| | Staphylococcus aureus | 1 | 2025 | 455 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2022 | 240 | 0.040 |
Why?
| | Metabolome | 1 | 2024 | 384 | 0.040 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2020 | 40 | 0.040 |
Why?
| | Hyaluronoglucosaminidase | 1 | 2020 | 7 | 0.040 |
Why?
| | Cell Respiration | 1 | 2020 | 107 | 0.040 |
Why?
| | Electron Transport Complex I | 1 | 2020 | 42 | 0.040 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2022 | 279 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 548 | 0.040 |
Why?
| | Antioxidant Response Elements | 1 | 2019 | 5 | 0.040 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2020 | 108 | 0.040 |
Why?
| | Oxidoreductases Acting on Sulfur Group Donors | 1 | 2019 | 10 | 0.040 |
Why?
| | Sirtuin 3 | 1 | 2020 | 60 | 0.040 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 1 | 2019 | 34 | 0.040 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2020 | 204 | 0.040 |
Why?
| | Time-to-Treatment | 1 | 2021 | 243 | 0.040 |
Why?
| | Heme Oxygenase-1 | 1 | 2019 | 74 | 0.040 |
Why?
| | Cell Hypoxia | 1 | 2020 | 247 | 0.040 |
Why?
| | Water | 2 | 2012 | 469 | 0.040 |
Why?
| | Metabolomics | 1 | 2024 | 727 | 0.030 |
Why?
| | Pulmonary Alveoli | 1 | 2021 | 383 | 0.030 |
Why?
| | Protein Kinases | 1 | 2020 | 315 | 0.030 |
Why?
| | Sulfonamides | 1 | 2022 | 580 | 0.030 |
Why?
| | Glomerular Filtration Rate | 1 | 2022 | 760 | 0.030 |
Why?
| | HIV | 1 | 2019 | 250 | 0.030 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2020 | 266 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2019 | 635 | 0.030 |
Why?
| | Up-Regulation | 1 | 2020 | 851 | 0.030 |
Why?
| | Radionuclide Imaging | 1 | 2016 | 112 | 0.030 |
Why?
| | Sex Factors | 1 | 2022 | 2112 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2022 | 1137 | 0.030 |
Why?
| | Signal-To-Noise Ratio | 1 | 2015 | 73 | 0.030 |
Why?
| | Crystallography, X-Ray | 1 | 2017 | 492 | 0.030 |
Why?
| | Cyclic N-Oxides | 1 | 2014 | 33 | 0.030 |
Why?
| | Blood Pressure | 1 | 2022 | 1769 | 0.030 |
Why?
| | Glucose | 1 | 2020 | 1047 | 0.030 |
Why?
| | Muramidase | 1 | 2014 | 67 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2022 | 3540 | 0.030 |
Why?
| | Pulmonary Artery | 1 | 2020 | 1134 | 0.030 |
Why?
| | Cell Line | 1 | 2019 | 2882 | 0.020 |
Why?
| | Apoptosis | 1 | 2022 | 2430 | 0.020 |
Why?
| | Viscosity | 1 | 2013 | 90 | 0.020 |
Why?
| | Solvents | 1 | 2013 | 113 | 0.020 |
Why?
| | Image Enhancement | 1 | 2014 | 199 | 0.020 |
Why?
| | Endothelial Cells | 1 | 2019 | 869 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2020 | 2496 | 0.020 |
Why?
| | Models, Molecular | 1 | 2017 | 1618 | 0.020 |
Why?
| | Isotope Labeling | 1 | 2011 | 82 | 0.020 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2014 | 780 | 0.020 |
Why?
| | Models, Statistical | 1 | 2013 | 681 | 0.020 |
Why?
| | Aged | 1 | 2022 | 25913 | 0.010 |
Why?
|
|
Elajaili's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|